Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Kawatani

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Chemical biology and novel molecular-targeted agents in cancer therapy]Makoto Kawatani, Hiroyuki Osada
The Journal of Biological Chemistry|March 20, 2003
Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashionMakoto Kawatani, Masaya Imoto
Cancer Science|August 14, 2009
Osteoclast-targeting small molecules for the treatment of neoplastic bone metastasesMakoto Kawatani, Hiroyuki Osada
Vitamins and Hormones|March 17, 2025
Small-molecule inhibitors of glucose transportersMakoto Kawatani, Hiroyuki Osada
Bioscience, Biotechnology, and Biochemistry|October 8, 2008
Robust and systematic drug screening method using chemical arrays and the protein library: identification of novel inhibitors of carbonic anhydrase IIIsao Miyazaki, Siro Simizu, Harumi Ichimiya, et al.
Experimental Cell Research|May 6, 2003
Transmembrane domain of Bcl-2 is required for inhibition of ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosisMakoto Kawatani, Madoka Uchi, Siro Simizu, et al.
The Biochemical Journal|July 12, 2014
A small molecule that induces reactive oxygen species via cellular glutathione depletionTatsuro Kawamura, Yasumitsu Kondoh, Makoto Muroi, et al.
The Journal of Antibiotics|July 2, 2015
An overproduction of astellolides induced by genetic disruption of chromatin-remodeling factors in Aspergillus oryzaeYasutomo Shinohara, Makoto Kawatani, Yushi Futamura, et al.
Oncology Research|June 22, 2012
The potential of protein disulfide isomerase as a therapeutic drug targetMaola M G Khan, Siro Simizu, Makoto Kawatani, et al.
Bioconjugate Chemistry|December 29, 2012
Dual structure-activity relationship of osteoclastogenesis inhibitor methyl gerfelin based on TEG scanningNaoki Kanoh, Takahiro Suzuki, Makoto Kawatani, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Chemical biology and novel molecular-targeted agents in cancer therapy]Makoto Kawatani, Hiroyuki Osada
The Journal of Biological Chemistry|March 20, 2003
Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashionMakoto Kawatani, Masaya Imoto
Cancer Science|August 14, 2009
Osteoclast-targeting small molecules for the treatment of neoplastic bone metastasesMakoto Kawatani, Hiroyuki Osada
Vitamins and Hormones|March 17, 2025
Small-molecule inhibitors of glucose transportersMakoto Kawatani, Hiroyuki Osada
Bioscience, Biotechnology, and Biochemistry|October 8, 2008
Robust and systematic drug screening method using chemical arrays and the protein library: identification of novel inhibitors of carbonic anhydrase IIIsao Miyazaki, Siro Simizu, Harumi Ichimiya, et al.
Experimental Cell Research|May 6, 2003
Transmembrane domain of Bcl-2 is required for inhibition of ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosisMakoto Kawatani, Madoka Uchi, Siro Simizu, et al.
The Biochemical Journal|July 12, 2014
A small molecule that induces reactive oxygen species via cellular glutathione depletionTatsuro Kawamura, Yasumitsu Kondoh, Makoto Muroi, et al.
The Journal of Antibiotics|July 2, 2015
An overproduction of astellolides induced by genetic disruption of chromatin-remodeling factors in Aspergillus oryzaeYasutomo Shinohara, Makoto Kawatani, Yushi Futamura, et al.
Oncology Research|June 22, 2012
The potential of protein disulfide isomerase as a therapeutic drug targetMaola M G Khan, Siro Simizu, Makoto Kawatani, et al.
Bioconjugate Chemistry|December 29, 2012
Dual structure-activity relationship of osteoclastogenesis inhibitor methyl gerfelin based on TEG scanningNaoki Kanoh, Takahiro Suzuki, Makoto Kawatani, et al.
Pageof 6